Bridgepoint announced today that it has agreed to sell Evac to Altor Equity Partners.
Evac provides cleantech solutions for marine and land-based markets. It focuses on water and waste management, corrosion protection, and marine growth prevention. Its systems support navies, cruise ships, and commercial fleets worldwide.
Evac was founded in 1979 and is based in Espoo, Finland. The company serves tens of thousands of vessels globally. It also runs a leading aftermarket business.
Evac expects EBITDA to reach about €47 million in 2025. Strong demand and major naval spending programs drive this growth.
Bridgepoint expanded Evac’s business during its ownership. The firm invested in research and development. It also completed six acquisitions. These moves strengthened Evac’s product range and global presence.
Bridgepoint also grew Evac’s aftermarket operations. Aftermarket and service revenues now exceed two-thirds of total revenue. This has made Evac’s business more stable and recurring.
Evac CEO Björn Ullbro welcomed the deal. He said the company is ready for its next growth phase. He added that demand for sustainable solutions is rising rapidly. He believes the partnership with Altor will help Evac scale faster.
Bridgepoint partners Patrick Fox and Christopher Bley praised Evac’s progress. They said the company now operates as a global leader with a strong portfolio and a resilient business model.
Bridgepoint has invested extensively in the Nordic region over the past 30 years. Evac is its fourth exit in two years. The firm previously sold Diaverum in 2023. It also partially exited Vitamin Well and Oris Dental in 2024.
The sale is expected to close in 2026. It remains subject to regulatory approvals. The companies did not disclose financial terms.
Citigroup advised Bridgepoint on the transaction. EY handled financial, tax, and technology due diligence. Avance provided legal advice. McKinsey delivered commercial due diligence.
